Mr. Abraham has more than 30 years of experience in the medical device industry, including executive leadership roles at Stryker, Amedica and Isotis Orthobiologics.
Most recently, he served as managing director of NuVasive’s Australia and New Zealand subsidiary, where he was responsible for the sales, marketing, operations and finance departments.
Prior to joining NuVasive, Mr. Abraham was senior vice president of global sales at Amedica and senior director of orthopedic trauma sales at Stryker.
More articles on devices:
AAOS, OREF partner to drive funding for biologic, total joint replacement research
NuVasive Q1 net income drops 43.6%, shares down 27% since start of year
Dr. Charles Branch Jr.: Imaging, patient engagement big opportunities in spine post-pandemic
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
